Identification of Risk Phenotypes for Sarcopenia Using DXA WBC, Anthropometric and MA Among Young Adults

Active, not recruitingOBSERVATIONAL
Enrollment

221

Participants

Timeline

Start Date

February 28, 2024

Primary Completion Date

May 31, 2024

Study Completion Date

March 1, 2025

Conditions
Sarcopenia
Interventions
COMBINATION_PRODUCT

Identification of Risk Phenotypes of Sarcopenia

Sarcopenia is a condition characterized by progressive loss of skeletal muscle mass, strength, and function, often associated with aging. Traditionally, it is studied in older populations, but your focus is on identifying its early manifestations in young adults, potentially offering a window for prevention.

Trial Locations (1)

54000

CENUM Center Mayo Hospital Rd, Anarkali Bazaar, Lahore

All Listed Sponsors
lead

Superior University

OTHER

NCT06739850 - Identification of Risk Phenotypes for Sarcopenia Using DXA WBC, Anthropometric and MA Among Young Adults | Biotech Hunter | Biotech Hunter